Skip to content

Serious Game for Parkinson's Disease Patients

Feasibility and Acceptability Study of Serious Game Rehabilitation Program in Parkinson's Disease Patients With Resistant Gait and Balance Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02469350
Acronym
PARKGAME
Enrollment
10
Registered
2015-06-11
Start date
2015-06-30
Completion date
2017-10-04
Last updated
2025-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Gait and balance disorders, serious game

Brief summary

In this study the investigators aim to assess the feasibility and acceptability of a serious game to rehabilitate gait and balance disorders in 10 patients with Parkinson's disease previously operated for deep brain stimulation of the sub thalamic nucleus.

Interventions

OTHERSerious game

Rehabilitation with serious game

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease * Gait and balance disorders * Chronic bilateral deep brain stimulation of the subthalamic nucleus (\> 1 year).

Exclusion criteria

* Dementia * Ongoing severe medical condition that prevented assessments

Design outcomes

Primary

MeasureTime frameDescription
Feasibility questionnaireonce a weekself-assessment questionnaire

Secondary

MeasureTime frameDescription
Acceptability questionnaireonce a weekself-assessment questionnaire
biomechanical parameters of gait and balanceat inclusion, 3 weeks, 6 weeks and 18 weeksrecordings of centres of foot and mass displacements and velocities
kinematics parameters of gait and balanceat inclusion, 3 weeks, 6 weeks and 18 weeksrange of motion of hip, knee and ankle angles

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026